Skadden – Valeant to Acquire Bausch & Lomb Wednesday, May 29, 2013 Tags: Skadden, Arps, Slate, Meagher & Flom LLP Skadden is representing Valeant Pharmaceuticals in its $8.7 billion acquisition of Bausch & Lomb, announced on May 27. www.skadden.com